Moderna and CytomX Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics
Go back to Moderna and CytomX Announce Strategic Research Collaboration for mRNA-Based Conditionally Activated Therapeutics| Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) | Delayed: 3.82 +0.22 (6.11%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.60 | 52 Week High | $24.68 | |||
| Open | $3.65 | 52 Week Low | $9.10 | |||
| Day High | $3.90 | P/E | N/A | |||
| Day Low | $3.60 | EPS | $0.00 | |||
| Volume | 5,123,578 | |||||
| Marina Biotech, Inc. (NASDAQ: MRNA) | Delayed: 79.76 +7.26 (10.01%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $72.50 | 52 Week High | $0.52 | |||
| Open | $73.71 | 52 Week Low | $0.08 | |||
| Day High | $81.40 | P/E | N/A | |||
| Day Low | $73.68 | EPS | $-3.80 | |||
| Volume | 14,112,278 | |||||
